NU SKIN ENTERPRISES, INC. Income (Loss) from Equity Method Investments
NU SKIN ENTERPRISES, INC. (NUS) reported Income (Loss) from Equity Method Investments of $0 for the 12-month period ending 2020-12-31, per its 10-K filed 2021-02-11.
Discontinued › Income Statement › Other Income
us-gaap:IncomeLossFromEquityMethodInvestments · last filed 2021-02-11
- NU SKIN ENTERPRISES, INC. income (loss) from equity method investments for the quarter ending 2019-12-31 was $0.00.
- NU SKIN ENTERPRISES, INC. income (loss) from equity method investments for the quarter ending 2019-09-30 was $0.00, a 100.00% decline year-over-year.
- NU SKIN ENTERPRISES, INC. income (loss) from equity method investments for the quarter ending 2019-06-30 was $0.00.
- NU SKIN ENTERPRISES, INC. income (loss) from equity method investments for the quarter ending 2019-03-31 was $0.00, a 100.00% decline year-over-year.
- NU SKIN ENTERPRISES, INC. income (loss) from equity method investments for fiscal 2020 was $0.00.
- NU SKIN ENTERPRISES, INC. income (loss) from equity method investments for fiscal 2019 was $0.00, a 100.00% decline from fiscal 2018.
- NU SKIN ENTERPRISES, INC. income (loss) from equity method investments for fiscal 2018 was $456.00K, a 56.49% decline from fiscal 2017.
- NU SKIN ENTERPRISES, INC. income (loss) from equity method investments for fiscal 2017 was $1.05M.
| Period end | Income (Loss) from Equity Method Investments 3 month | Income (Loss) from Equity Method Investments 6 month | Income (Loss) from Equity Method Investments 9 month | Income (Loss) from Equity Method Investments 12 month |
|---|---|---|---|---|
| 2020-12-31 | $0.00 10-K · filed 2021-02-11 | |||
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-11 | $0.00 derived: sum of 2 quarters · filed 2021-02-11 | $0.00 derived: sum of 3 quarters · filed 2021-02-11 | $0.00 10-K · filed 2021-02-11 |
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-06 | $0.00 derived: sum of 2 quarters · filed 2019-11-06 | $0.00 10-Q · filed 2019-11-06 | $0.00 derived: sum of 4 quarters · filed 2021-02-11 |
| 2019-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-07 | $0.00 10-Q · filed 2019-08-07 | $0.00 derived: sum of 3 quarters · filed 2021-02-11 | $413.00K derived: sum of 4 quarters · filed 2021-02-11 |
| 2019-03-31 | $0.00 10-Q · filed 2019-05-01 | $0.00 derived: sum of 2 quarters · filed 2021-02-11 | $413.00K derived: sum of 3 quarters · filed 2021-02-11 | $0.00 derived: sum of 4 quarters · filed 2021-02-11 |
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-11 | $413.00K derived: sum of 2 quarters · filed 2021-02-11 | $0.00 derived: sum of 3 quarters · filed 2021-02-11 | $456.00K 10-K · filed 2021-02-11 |
| 2018-09-30 | $413.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-06 | $0.00 derived: sum of 2 quarters · filed 2019-11-06 | $456.00K 10-Q · filed 2019-11-06 | $849.00K derived: sum of 4 quarters · filed 2020-02-13 |
| 2018-06-30 | -$413.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-07 | $43.00K 10-Q · filed 2019-08-07 | $436.00K derived: sum of 3 quarters · filed 2020-02-13 | $733.00K derived: sum of 4 quarters · filed 2020-02-13 |
| 2018-03-31 | $456.00K 10-Q · filed 2019-05-01 | $849.00K derived: sum of 2 quarters · filed 2020-02-13 | $1.15M derived: sum of 3 quarters · filed 2020-02-13 | $1.40M derived: sum of 4 quarters · filed 2020-02-13 |
| 2017-12-31 | $393.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-13 | $690.00K derived: sum of 2 quarters · filed 2020-02-13 | $944.00K derived: sum of 3 quarters · filed 2020-02-13 | $1.05M 10-K · filed 2020-02-13 |
| 2017-09-30 | $297.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-08 | $551.00K derived: sum of 2 quarters · filed 2018-11-08 | $655.00K 10-Q · filed 2018-11-08 | $655.00K derived: sum of 4 quarters · filed 2019-02-14 |
| 2017-06-30 | $254.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-03 | $358.00K 10-Q · filed 2018-08-03 | $358.00K derived: sum of 3 quarters · filed 2019-02-14 | $358.00K derived: sum of 4 quarters · filed 2019-02-14 |
| 2017-03-31 | $104.00K 10-Q · filed 2018-04-27 | $104.00K derived: sum of 2 quarters · filed 2019-02-14 | $104.00K derived: sum of 3 quarters · filed 2019-02-14 | $104.00K derived: sum of 4 quarters · filed 2019-02-14 |
| 2016-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-14 | $0.00 derived: sum of 2 quarters · filed 2019-02-14 | $0.00 derived: sum of 3 quarters · filed 2019-02-14 | $0.00 10-K · filed 2019-02-14 |
| 2016-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-02 | $0.00 derived: sum of 2 quarters · filed 2017-11-02 | $0.00 10-Q · filed 2017-11-02 | |
| 2016-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-03 | $0.00 10-Q · filed 2017-08-03 | ||
| 2016-03-31 | $0.00 10-Q · filed 2017-05-04 | |||
| 2015-12-31 | $0.00 10-K · filed 2018-02-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cosmos Health Inc. (COSM) | Greece | $0.038B | -0.60 |
| HWH International Inc. (HWH) | United States | $0.021B | -4.08 |
| DataMeds AI, Inc. (MEDS) | United States | $0.011B | |
| HERBALIFE LTD. (HLF) | $1.281B | 8.39 | |
| CARDINAL HEALTH INC (CAH) | United States | $51.753B | 29.38 |
| Cencora, Inc. (COR) | United States | $59.130B | 20.57 |
| MCKESSON CORP (MCK) | United States | $101.317B | 19.78 |